Concepedia

Author

Elisabet Hjerpe

Karolinska InstitutetORCID

Also Known As

E Hjerpe, E. Hjerpe, Elisabet Hjerpe

45

Publications

698

Citations

13

H-Index

21

Concepts

All Affiliations

Karolinska InstitutetKarolinska University HospitalSkåne University HospitalLinköping UniversityUppsala University
EH

About

Elisabet Hjerpe is an author at Karolinska Institutet specializing in oncology, medicine, and gynecology oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

108

2

Obstetrics

2

2

38

3

Public Health

1

1

19

4

Cell Biology

1

1

70

5

Pathology

1

1

19

Elisabet Hjerpe

×

14

Publications

665

Citations

13

H-Index

YearCitations

Lymphovascular space invasion as a predictive factor for lymph node metastases and survival in endometrioid endometrial cancer – a Swedish Gynecologic Cancer Group (SweGCG) study

Karin Stålberg, Maria Bjurberg, Christer Borgfeldt,

Acta Oncologica

2019

92

Genome-wide association study identifies ephrin type A receptors implicated in paclitaxel induced peripheral sensory neuropathy

Luis J. Leandro‐García, Lucía Inglada‐Pérez, Guillermo Pita,

Journal of Medical Genetics

2013

79

Adaptive RSK‐EphA2‐GPRC5A signaling switch triggers chemotherapy resistance in ovarian cancer

Lidia Moyano‐Galceran, Elina Pietilä, S. Pauliina Turunen,

EMBO Molecular Medicine

2020

70

Protein markers of cancer-associated fibroblasts and tumor-initiating cells reveal subpopulations in freshly isolated ovarian cancer ascites

My Wintzell, Elisabet Hjerpe, Elisabeth Åvall Lundqvist,

BMC Cancer

2012

66

Data quality in the Swedish Quality Register of Gynecologic Cancer – a Swedish Gynecologic Cancer Group (SweGCG) study

Per Rosenberg, Preben Kjølhede, Christian Staf,

Acta Oncologica

2017

66

HSP60 Predicts Survival in Advanced Serous Ovarian Cancer

Elisabet Hjerpe, Suzanne Egyházi, Joseph W. Carlson,

International Journal of Gynecological Cancer

2013

59

Chemotherapy vs tamoxifen in platinum-resistant ovarian cancer: a phase III, randomised, multicentre trial (Ovaresist)

Kristina Lindemann, Emma Gibbs, Elisabeth Åvall‐Lundqvist,

British Journal of Cancer

2017

50

Metabolic markers GAPDH, PKM2, ATP5B and BEC-index in advanced serous ovarian cancer

Elisabet Hjerpe, Joseph W. Carlson, Marianne Frostvik Stolt,

BMC Clinical Pathology

2013

47

Ovarian carcinoma cells with low levels of β-F1-ATPase are sensitive to combined platinum and 2-deoxy-<scp>d</scp>-glucose treatment

E Hernlund, Elisabet Hjerpe, Elisabeth Åvall‐Lundqvist,

Molecular Cancer Therapeutics

2009

41

Lymph node metastases as only qualifier for stage IV serous ovarian cancer confers longer survival than other sites of distant disease – a Swedish Gynecologic Cancer Group (SweGCG) study

Elisabet Hjerpe, Christian Staf, Pernilla Dahm‐Kähler,

Acta Oncologica

2017

27

Page 1